Retinoic acid alters the intracellular trafficking of the mannose-6-phosphate/insulin-like growth factor II receptor and lysosomal enzymes.

Previously, we showed that retinoic acid (RA) binds to the mannose-6-phosphate/insulin-like growth factor II receptor (M6P/IGF2R) with high affinity, suggesting that M6P/IGF2R may be a receptor for RA. Here, we show that RA, after 2-3 h of incubation with cultured neonatal-rat cardiac fibroblasts, dramatically alters the intracellular distribution of M6P/IGF2R as well as that of cathepsin B (a lysosomal protease bearing M6P). Immunofluorescence techniques indicate that this change in intracellular distribution is characterized by a shift of the proteins from the perinuclear area to cytoplasmic vesicles. The effect of RA was neither blocked by an RA nuclear receptor antagonist (AGN193109) nor mimicked by a selective RA nuclear-receptor agonist (TTNPB). Furthermore, the RA-induced translocation of cathepsin B was not observed in M6P/IGF2R-deficient P388D1 cells but occurred in stably transfected P388D1 cells expressing the receptor, suggesting that the effect of RA might be the result of direct interaction with M6P/IGF2R, rather than the result of binding to the nuclear receptors. These observations not only support the idea that M6P/IGF2R mediates an RA-response pathway but also indicate a role for RA in control of intracellular trafficking of lysosomal enzymes. Therefore, our observations may have important implications for the understanding of the diverse biological effects of retinoids.

[1]  J. Falls,et al.  Imprinted M6p/Igf2 receptor is mutated in rat liver tumors , 1998, Oncogene.

[2]  D. Mangelsdorf,et al.  Synthesis of high specific activity [3H]-9-cis-retinoic acid and its application for identifying retinoids with unusual binding properties. , 1994, Journal of medicinal chemistry.

[3]  A. Kimchi,et al.  Cathepsin D protease mediates programmed cell death induced by interferon‐gamma, Fas/APO‐1 and TNF‐alpha. , 1996, The EMBO journal.

[4]  S. Finkelstein,et al.  Loss of the gene encoding mannose 6-phosphate/insulin-like growth factor II receptor is an early event in liver carcinogenesis. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[5]  M. Czech,et al.  Direct demonstration of rapid insulin-like growth factor II Receptor internalization and recycling in rat adipocytes. Insulin stimulates 125I-insulin-like growth factor II degradation by modulating the IGF-II receptor recycling process. , 1985, The Journal of biological chemistry.

[6]  J. Welsh,et al.  Characterization of a vitamin D3-resistant MCF-7 cell line. , 1996, Endocrinology.

[7]  R. Chandraratna,et al.  Synthesis and characterization of a highly potent and effective antagonist of retinoic acid receptors. , 1995, Journal of medicinal chemistry.

[8]  C. M. Nolan,et al.  Expression of human cation-independent mannose 6-phosphate receptor cDNA in receptor-negative mouse P388D1 cells following gene transfer. , 1988, The Journal of biological chemistry.

[9]  Ziying Liu,et al.  Loss of the imprinted IGF2/cation-independent mannose 6-phosphate receptor results in fetal overgrowth and perinatal lethality. , 1994, Genes & development.

[10]  A. Leaf,et al.  Mannose-6-phosphate/insulin-like growth factor-II receptor is a receptor for retinoic acid. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[11]  D. Goldberg,et al.  Identification and characterization of cells deficient in the mannose 6-phosphate receptor: evidence for an alternate pathway for lysosomal enzyme targeting. , 1983, Proceedings of the National Academy of Sciences of the United States of America.

[12]  W. Meyers,et al.  Transforming Growth Factor‐Beta Receptors and Mannose 6‐Phosphate/Insulin‐Like Growth Factor‐II Receptor Expression in Human Hepatocellular Carcinoma , 1995, Annals of surgery.

[13]  M. Washington,et al.  M6P/IGF2R gene is mutated in human hepatocellular carcinomas with loss of heterozygosity , 1995, Nature Genetics.

[14]  R. Bentley,et al.  M6P/IGF2 receptor: a candidate breast tumor suppressor gene. , 1996, Oncogene.

[15]  D. Sleat,et al.  Mouse mutants lacking the cation-independent mannose 6-phosphate/insulin-like growth factor II receptor are impaired in lysosomal enzyme transport: comparison of cation-independent and cation-dependent mannose 6-phosphate receptor-deficient mice. , 1998, The Biochemical journal.

[16]  T. Ludwig,et al.  Mouse mutants lacking the type 2 IGF receptor (IGF2R) are rescued from perinatal lethality in Igf2 and Igf1r null backgrounds. , 1996, Developmental biology.

[17]  B. Hales,et al.  Induction of apoptosis and cathepsin D in limbs exposed in vitro to an activated analog of cyclophosphamide. , 1995, Teratology.

[18]  S. Kornfeld.  Structure and function of the mannose 6-phosphate/insulinlike growth factor II receptors. , 1992, Annual review of biochemistry.

[19]  Z. Piao,et al.  Deletion of the M6P/IGF2r gene in primary hepatocellular carcinoma. , 1997, Cancer letters.

[20]  M. Garst,et al.  Synthesis and structure-activity relationships of stilbene retinoid analogs substituted with heteroaromatic carboxylic acids. , 1995, Journal of medicinal chemistry.

[21]  S. Nagpal,et al.  Identification and Functional Separation of Retinoic Acid Receptor Neutral Antagonists and Inverse Agonists* , 1996, The Journal of Biological Chemistry.

[22]  H. Kresse,et al.  Biosynthesis of cathepsin B in cultured normal and I-cell fibroblasts. , 1987, The Journal of biological chemistry.

[23]  R. Eckert,et al.  AGN193109 Is a Highly Effective Antagonist of Retinoid Action in Human Ectocervical Epithelial Cells (*) , 1996, The Journal of Biological Chemistry.

[24]  D. Rifkin,et al.  Cellular activation of latent transforming growth factor beta requires binding to the cation-independent mannose 6-phosphate/insulin-like growth factor type II receptor. , 1991, Proceedings of the National Academy of Sciences of the United States of America.